INSIDE Drug Discovery and Development: Focus on Respiratory
Welcome to INSIDE Drug Discovery and Development, our very own publication which brings together our latest thinking and insights in all things drug discovery. This edition focuses on the respiratory disease therapeutic area and is written by our Director of Respiratory, Vince Russell.
This issue discusses the current status/understanding of drug discovery in the respiratory disease area. Particular focus is given to idiopathic pulmonary fibrosis (IPF), cystic fibrosis (CF) and asthma.
Key to progress in all of these areas, and other respiratory diseases of course, is the availability of appropriate technologies, capabilities and translational models to ensure that we maximise the chances of success as compounds/projects progress and avoid wasting time and effort on concepts that will not succeed. As new tools become available they will help to understand and refine our preclinical models, including the identification and use of improved translational biomarkers, to better predict which emerging therapies will deliver desired outcomes for patients, including disease modifying treatments.
Download your copy now and discover more about the latest trends in respiratory and what the future of this therapeutic area looks like.